Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Drugs Made In America Acquisition Corp. (DMAA) vs Dynamix Corporation III (DNMX)

Drugs Made In America Acquisition Corp. and Dynamix Corporation III are both Shell Companies companies. Drugs Made In America Acquisition Corp. and Dynamix Corporation III are of similar size ($269.7M and $263.4M).

Valuation

Metric DMAA DNMX Shell Companies median
P/E — — 39.97
P/S — n/m 12.19
P/B — n/m 2.01
Price to free cash flow — n/m 28.89
EV/EBITDA — n/m —
EV/Sales — n/m —
Earnings yield — — 1.63%
Free cash flow yield — 0.00% (0.79%)

Profitability

Metric DMAA DNMX Shell Companies median
Gross margin — — 71.01%
Operating margin — — 0.00%
Net margin — — 0.00%
Free cash flow margin — — 0.00%
Return on equity — — 1.91%
Return on assets — — 2.03%
Return on invested capital — 0.00% 0.00%

Growth

Metric DMAA DNMX Shell Companies median
Revenue growth (TTM) — — —
EPS growth (last fiscal year) — — —
Revenue growth, 5-year CAGR — — —
Net income growth, 5-year CAGR — — 0.00%

Health

Metric DMAA DNMX Shell Companies median
Debt to equity — (0.02) 0.00
Current ratio — 1.41 0.08
Net debt to EBITDA — 2.55 0.06

Dividend

Metric DMAA DNMX Shell Companies median
Dividend yield — — —
Payout ratio — — 0.00

Size

Metric DMAA DNMX Shell Companies median
Market cap 263.40m 269.68m 154.76m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack